Budget Impact Analysis: Methods & Data Mark W. Smith, PhD VA HSR&D Health Economics Resource Center 795 Willow Road (152 MPD), Menlo Park, CA 94025.

Slides:



Advertisements
Similar presentations
Health Economics and ONS
Advertisements

Cost-Effectiveness Using Decision-Analytic Models
Introduction to Pharmacoeconomics
HERU is supported by the Chief Scientist Office of the Scottish Government Health Directorates and the University of Aberdeen. The author accepts full.
Economic Analysis and Management Todd Wagner, PhD.
VA Health Economics Course Presentation # 3: Costing Methods April 6, 2006.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Clare A Mackie Centre for Partnerships in Medicines for Health Economic Evaluation of a RCT of a ‘Medication Review Clinic’ in Patients Receiving Repeat.
COST–EFFECTIVENESS ANALYSIS AND COST-UTILITY ANALYSIS
Decision Trees Farrokh Alemi, Ph.D.. Coming Up How to construct a decision tree? –Components of a tree –Interviewing decision makers How to analyze a.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2009.
Productivity Prepared by Dr. Manal Moussa. Productivity Prepared by Dr. Manal Moussa.
AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).
Cost-Benefit Analysis (CBA) Illustrated by the California GAIN Random Assignment Experiment.
Budget Impact Analysis and Return on Investment Usa Chaikledkaew, Ph.D.
1 Managed Health Care Pricing for Provider Arrangements Presented by Vanessa Olson Seminar on Health and Managed Care October 18, 1999.
The Hilltop Health Care Reform Simulation Model Hamid Fakhraei, Ph.D. July 2012.
Assessing Health and Economic Outcomes William C. Black, M.D. Director ACRIN Outcomes & Economics Core Laboratory Dartmouth-Hitchcock Medical Center.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Budget Impact Analysis A worked example
Disease Management: High Risk Groups Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
Pharmacy Data Mark W. Smith, PhD April Topics Overview of Data Sources Access & File Names Highlights of Contents Guidance for Use Non-VA Pharmacy.
Racial Differences in Quality of Care for Bipolar Disorder Center for Health Equity Research and Promotion Departments of Medicine and Psychiatry, University.
Estimating Cost at Each Stage of Care Mark Smith, PhD Paul Barnett, PhD Ciaran Phibbs, PhD HERC Cyberseminar February 28, 2007.
PHAR 310: Pharmacoeconomics
Consumer-Driven Health Plans: Early Evidence about Utilization, Spending and Cost Stephen T Parente Roger Feldman Jon B Christianson October, 2003.
EVIDENCE BASED MEDICINE Health economics Ross Lawrenson.
What cost evidence supports the use of technologies in home and community based caregiving of older adults? Presented by Brooke Harrow, PhD University.
Inpatient, Outpatient, and Pharmacy Costs from the Decision Support System (DSS) Jean Yoon October 3, 2012.
1 Estimating non-VA Health Care Costs Todd H. Wagner.
VA Health Care Data at the Austin Automation Center Paul G. Barnett, PhD April 4, 2003.
Budget Impact Analysis: Methods & Data Patsi Sinnott, PT, PhD November 28, 2012.
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
Mohammad Aljawadi PharmD, PhD Clinical Pharmacy Department King Saud University PHCL 431 Sep, 2015.
Budget Impact Analysis: Methods & Data Mark W. Smith, PhD May 12, 2010 VA HSR&D Health Economics Resource Center 795 Willow Road (152 MPD), Menlo Park,
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
Disease Burden, Utilization and Costs of Care Among Women Using Veterans Health Administration HERC Cyber Seminar May 25, 2005 Presented by Ciaran Phibbs.
Enhancing Equitable and Effective PTSD Disability Assessment (E3-PTSD) Ted Speroff, PhD, PI; TVHCS Patricia Sinnott, PT, PhD, MPH, co-PI;HERC.
Inpatient and Outpatient Costs from DSS Jean Yoon Paul Barnett March 25, 2009.
Fee Basis & NPPD Data Mark W. Smith, Ph.D. August 3, 2005 Health Economics Teleconference Seminar access code
An Overview of VA Pharmacy Data Mark W. Smith February, 2010.
PHARMACOECONOMICS Dr. Mohammad Aljawadi, PharmD PhD Department of Clinical Pharmacy King Saud University Aug, 2015 PHCL 431.
Mark W. Smith July 28, 2010 Fee Basis Data. Overview of Fee Basis Program Pays for care at non-VA facilities when –it is the only source available, or.
Fiscal Planning (Budgeting). Fiscal Planning Fiscal planning is not intuitive; it is a learned skill that improves with practice. Fiscal planning requires.
VA Decision Support System (DSS) Paul G. Barnett PhD Wei Yu, PhD Samuel King, MS Ciaran Phibbs, PhD July 20, 2005.
VA Economic Data Sets I: Utilization Paul G. Barnett, PhD June 15, 2005 VA Health Economics Course.
Cost-Benefit Analysis (CBA) Illustrated by the California GAIN Random Assignment Experiment.
Oregon's Coordinated Care Organizations: First Year Expenditure and Utilization Authors: Neal Wallace, PhD, Peter Geissert, MPH 1, and K. John McConnell,
VA Economic Data Sets: CDR, MPCR, Person-level cost Todd Wagner.
Pharmacy Data Mark W. Smith, PhD July 13, 2005 Health Economics Teleconference Seminar access code
Flagship Program on Health Sector Reform and Sustainable Financing.
Inpatient and Outpatient Costs from DSS Jean Yoon Paul Barnett February 10, 2010.
Advances in VA Utilization and Cost Data VA HSR&D National Meeting February 16, 2005 Mark W. Smith Paul Barnett Todd Wagner.
Estimating the Cost of Health Care: VA Costs Paul Barnett May 16, 2007.
Conceptual Addition of Adherence to a Markov Model In the adherence-naïve model, medication adherence and associated effectiveness assumed to be trial.
UCSF, Decision Support Services 1 FY08 PSA Budget Overview Decision Support Services.
Economics of Complementary and Integrative Medicine: Where Do We Go From Here? Patricia M. Herman, ND, PhD, RAND Corporation IM4US Boston August 8, 2014.
Inpatient, Outpatient, and Pharmacy Costs from DSS Jean Yoon October 12, 2011.
Budget Impact Analysis: Methods & Data Patsi Sinnott, PT, PhD February 1, 2012.
Micro-cost Methods of Finding VA Costs Mark W. Smith, PhD Paul G. Barnett, PhD HERC Economics Course March 16, 2005.
‘PhysioDirect’ for patients with MSK problems ECONOMIC MODEL OVERVIEW.
ACTIVITY-BASED COSTING (ABC)
Cost effectiveness Analysis: Valuing Health; Valuing Research!
Chapter 10: Cost-Effectiveness and Cost Analysis Designs
HEALTH ECONOMICS BASICS
Advances in VA Utilization and Cost Data
CONTROLLING THE COSTS OF HEMOPHILIA
A Primer on Health Economics and Cost-Effectiveness
Presentation transcript:

Budget Impact Analysis: Methods & Data Mark W. Smith, PhD VA HSR&D Health Economics Resource Center 795 Willow Road (152 MPD), Menlo Park, CA 94025

Budget Impact Analysis: Overview Analysis of provider’s expenditures for a program over a short period (often 1-3 years), including the effect of any offsetting savings. –Evaluates a scenario rather than a single action –Includes comparison to the status quo –Includes sensitivity analysis

Budget Impact Analysis: Perspective BIA takes the provider/payer’s perspective. Meaning BIA excludes patient-incurred costs. * but * BIA should reflect impacts on enrollment and retention that could result from affecting patients.

Budget Impact Analysis: Perspective BIA takes the provider/payer’s perspective. Practical Effects Ignoring patient and societal costs will make many interventions appear less expensive in a BIA than in a CEA. BIA can usually be done without surveying patients.

Budget Impact Analysis: Horizon BIA uses a short horizon – usually a few years at most. Practical Effect Long-term modeling of costs and clinical outcomes is unnecessary. Costs are not usually adjusted for inflation or discounting. Reductions in health costs in far future cannot offset initial costs.

Budget Impact Analysis: Utility BIA does not measure utility. Practical Effect No need to survey patients. No calculation of QALYs. Limitation No way to capture changes in quality of life

Budget Impact Analysis: Drawbacks - Some benefits cannot easily be monetized, such as reputation. - Prestigious journals often won’t publish them. - Costs can vary from site to site --> To increase usefulness, create a method for inputting local parameters.  Complement of CEA, not substitute

Why Both CEA and BIA? CEA addresses societal perspective  implementation won’t occur without proof that “best practice” is cost-effective BIA addresses provider perspective  influential in implementation decisions

Reference scenario Describes current health care delivery method & outcomes - How many patients are getting care - Who gets care (clinical characteristics, copay status, VERA payment level, etc.) - Among those who get care, * what care they get initially * what care they get later (through end of BIA horizon) - Total cost over time for this scenario

Comparison scenario Describes alternative health care scenario. Relative to reference scenario, how will these change? - Demand for care (number of patients seeking care) - Future need for care, within BIA horizon - Copayments collected, VERA payments received - Staff mix & consequent costs - Space and other overhead costs - Technology purchase/repair costs

Modeling Static models –Simple calculation of cost impact from changing one or two factors, holding everything else constant –May be sufficient if the alternative and reference scenarios are quite similar and probabilities are well known Dynamic models –Decision model, such as a Markov model: captures uncertainty, such as over impact on enrollment or probability of clinical outcomes –Discrete event analysis

BIA in Implementation Research Include cost of implementation program Consider: - How long will implementation costs last? - How generalizable is the local implementation approach? You may need to develop alternative scenarios for other locations.

Cost Data Sources: Encounters Decision Support System (DSS) National Data Extracts (NDEs) –Inpatient files discharge (one record per stay) bedsection (one record per bedsection segment of the stay) –Outpatient files Encounters: one record per person-clinic-day Pharmacy: one record per prescription

Cost Data Sources: Staff Average hourly staff cost for 70+ occupation categories can be figured using either of two sources: - DSS ALBCC - Financial Management System OR Use HERC technical report #12 supplement, which has figured them for FY2001-FY2006. ** FY2007 and FY2008 coming in 2009 **

Cost Data Sources: Supplies, Machines * National Prosthetics Patient Database (NPPD) - records purchase price of all items ordered through the VISTA Prosthetics and Sensory Aids package - includes nearly all medical items for internal and external use, not just prosthetics or sensory aids (glasses, hearing aids) - stored and handled by NPPD data manager at Hines VAMC * Your local A&MMS purchasing officer

Cost Data Sources: Indirects PG Barnett, M Berger. Indirect Costs of Specialized VA Mental Health Treatment. HERC Technical Report #6.Indirect Costs of Specialized VA Mental Health Treatment (see handout; also on HERC web site) Rosenheck R, Neale M, Frisman L. Issues in estimating the cost of innovative mental health programs. Psychiatric Quarterly 1995;66(1):9-31 (see handout)

Resources HERC web site ( - Guidebooks - Technical reports - FAQ responses - Slides from training courses (cyber-seminars) VIREC web site ( - Research user guides (RUGs) on DSS, PTF, OPC - Technical reports (pharmacy)

Resources Many articles on decision modeling and discrete event analysis appear in these journals: Medical Decision Making Health Economics Value in Health

Resources HSR&D web site – cyber-seminar catalog, including downloadable recordings of seminars: cyber_seminars/catalog.cfm Send questions on economic methods and data to HERC: or